ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
January 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
From Capitol Hill: Nuclear is back, critical for America’s energy future
The U.S. House Energy and Commerce Subcommittee on Energy convened its first hearing of the year, “American Energy Dominance: Dawn of the New Nuclear Era,” on January 7, where lawmakers and industry leaders discussed how nuclear energy can help meet surging electricity demand driven by artificial intelligence, data centers, advanced manufacturing, and national security needs.
D. Broggio, J. Janeczko, S. Lamart, E. Blanchardon, N. Borisov, A. Molokanov, V. Yatsenko, D. Franck
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 824-831
MC Calculations | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9313
Articles are hosted by Taylor and Francis Online.
In vivo measurements are usually carried out under the hypothesis of a known activity distribution inside the body. The measurements and the interpretation of in vivo measurements performed with the minimum hypothesis about the activity distribution are presented and discussed. Measurements have been performed with a devoted four-germanium-detector system on a male subject presenting a 30-yr-old wound contamination by americium and plutonium isotopes. The measurements have been processed after the construction of voxelized phantoms of the measured body parts and Monte Carlo (MC) calculations of organ- and detector-specific counting efficiencies. The phantom construction and MC calculations were assisted by the OEDIPE software, and the reliability of the modeling has been controlled by a comparison of the measured and simulated efficiencies for point-source measurements and for the measurement of a Spitz anthropomorphic knee phantom. Mainly based on measurements at the knee level, the 241Am specific bone activity was (0.27 ± 23%) Bq/g. Using measurements at the thorax level, no activity could be detected in the lungs; the liver activity was between 410 and 460 Bq. The activity of the axillary, thoracic airways and trunk lymph nodes depends on the retained hypothesis, but a reasonable assessment for the axillary lymph nodes is between 100 and 350 Bq.